GENE ONLINE|News &
Opinion
Blog

Immuno-oncology
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
Merck set to acquire Tilos Therapeutics for $773 million
2019-06-12
Weekly Top 5 in China (0310-0316)
2019-03-19
Weekly Top 5 in China (0217-0223)
2019-02-22
Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 1 Program
2018-11-22Partner
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
1 2
LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top